文献速递消化内镜消化道肿瘤与早癌

家族性腺瘤性息肉病患者十二指肠腺瘤的内镜管理

Endoscopic management of duodenal adenomas in patients with familial adenomatous polyposis.
PubMed 文献 · Gastrointest Endosc · 2020-06-11

本研究为历史性队列研究,纳入2002年至2018年接受内镜下十二指肠干预的家族性腺瘤性息肉病(FAP)患者49例,共68次内镜操作、139次十二指肠息肉切除术。息肉切除术后出血9例(13%)、穿孔1例(2%),乳头切除术后者出血6例(21%)、胰腺炎4例(14%)、穿孔1例(3%),均经内镜或保守处理。息肉切除术后89个月无十二指肠手术生存率为74%,乳头切除术后71个月为71%,无十二指肠癌发生;息肉切除术后Spigelman分期显著降低(P < .01)。

要点

  • FAP患者预防性十二指肠息肉切除术相对安全,出血9例(13%)、穿孔1例(2%),均经内镜处理。
  • 乳头切除术不良事件较多:出血6例(21%)、胰腺炎4例(14%)、穿孔1例(3%),需仔细权衡获益与风险。
  • 息肉切除术后89个月无手术生存率74%,乳头切除术后71个月为71%,均无十二指肠癌发生。

核心结论

  • 在本中心FAP患者中,预防性十二指肠息肉切除术相对安全;乳头切除术不良事件较多,其获益与风险应仔细权衡;两者均有效,因为手术干预有限且无一例发生十二指肠癌。

研究设计与样本

  • 历史性队列研究,纳入2002年至2018年接受内镜下十二指肠干预的FAP患者49例,共68次内镜操作、139次十二指肠息肉切除术;49例中20例为男性,中位年龄43岁;29例(14例男性,中位年龄49岁)接受乳头切除术。

主要发现

  • 息肉切除术后出血9例(13%)、穿孔1例(2%),均经内镜处理;乳头切除术后出血6例(21%,经内镜处理)、胰腺炎4例(14%)、穿孔1例(3%,保守治疗)。
  • 息肉切除术后89个月无十二指肠手术生存率为74%,乳头切除术后71个月为71%;未观察到十二指肠癌。
  • 息肉切除术后中位18个月(四分位距10-40,范围3-121)时Spigelman分期显著降低(P < .01)。

临床怎么用

  • 在本中心FAP患者中,预防性十二指肠息肉切除术相对安全;乳头切除术不良事件较多,其获益与风险应仔细权衡;两者均有效,因为手术干预有限且无一例发生十二指肠癌。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: Almost all patients with familial adenomatous polyposis (FAP) develop duodenal adenomas, with a 4% to 18% risk of progression into duodenal cancer. Prophylactic endoscopic resection of duodenal adenomas may prevent cancer and is considered safer than surgical alternatives; however, data are limited. Therefore, the aim of this study was to assess safety and effectiveness of endoscopic duodenal interventions in patients with FAP. METHODS: We performed a historical cohort study including patients with FAP who underwent an endoscopic duodenal intervention between 2002 and 2018. Safety was defined as adverse event rate per intervention and effectiveness as duodenal surgery-free and duodenal cancer-free survival. Change in Spigelman stage was assessed as a secondary outcome. RESULTS: In 68 endoscopy sessions, 139 duodenal polypectomies were performed in 49 patients (20 men; median age, 43). Twenty-nine patients (14 men; median age, 49) underwent a papillectomy. After polypectomy, 9 (13%) bleedings and 1 (2%) perforation occurred, all managed endoscopically. Six (21%) bleedings (endoscopically managed), 4 (14%) cases of pancreatitis, and 1 (3%) perforation (conservatively treated) occurred after papillectomy. Duodenal surgery-free survival was 74% at 89 months after polypectomy and 71% at 71 months after papillectomy; no duodenal cancers were observed. After a median of 18 months (interquartile range, 10-40; range, 3-121) after polypectomy, Spigelman stages were significantly lower (P < .01). CONCLUSIONS: In our FAP patients, prophylactic duodenal polypectomies were relatively safe. Papillectomies showed substantial adverse events, suggesting its benefits and risk should be carefully weighted. Both were effective, however, because surgical interventions were limited and none developed duodenal cancer.

来源:Gastrointest Endosc,查看原文。版权归原作者所有。

引用

  1. Roos VH, Bastiaansen BA, Kallenberg FGJ, et al. Endoscopic management of duodenal adenomas in patients with familial adenomatous polyposis. Gastrointest Endosc. 2020. PMID: 32535190. doi:10.1016/j.gie.2020.05.065

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。